Comparative Study
Immunoglobulins and complement components levels in patients with lung cancer
Affiliations
- PMID: 1323139
Item in Clipboard
Comparative Study
Immunoglobulins and complement components levels in patients with lung cancer
Rom J Intern Med.
1992 Jan-Mar.
Abstract
Sera from 96 patients with lung cancer were assayed in order to evaluate the concentrations of IgG, IgA, IgM, C3c and C4. Histologically, 49 of the patients had squamous cell carcinoma, 11--adenocarcinoma, 20--small cell carcinoma and 16--not identified lung cancer. No statistically significant differences were found between the concentrations of IgG and IgM in patients with carcinoma of the lung versus subjects in the control group. Both serum IgA and complement components (C30 and C4) were significantly elevated in almost all patients from the tumor group as compared with the levels in the control group.
Similar articles
-
Immunoglobulins and complement components in patients with lung cancer.Tuberk Toraks. 2004;52(1):19-23. Tuberk Toraks. 2004. PMID: 15143368
-
[Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].Zentralbl Bakteriol Mikrobiol Hyg B. 1985 Mar;180(4):381-93. Zentralbl Bakteriol Mikrobiol Hyg B. 1985. PMID: 2988233 German.
-
Immunocomplexes and primary lung cancer.Allergol Immunopathol (Madr). 1981 Mar-Apr;9(2):119-22. Allergol Immunopathol (Madr). 1981. PMID: 6270995
-
[Serum concentration of C3 in primary lung cancer patients].Arch Monaldi. 1980 Jul-Aug;35(4):169-74. Arch Monaldi. 1980. PMID: 6282231 Italian. No abstract available.
-
Tumor-associated immunoglobulins in pulmonary carcinoma.Cancer Res. 1977 Dec;37(12):4449-55. Cancer Res. 1977. PMID: 200349
Cited by
-
A Panel of Genetic Polymorphism for the Prediction of Prognosis in Patients with Early Stage Non-Small Cell Lung Cancer after Surgical Resection.PLoS One. 2015 Oct 13;10(10):e0140216. doi: 10.1371/journal.pone.0140216. eCollection 2015. PLoS One. 2015. PMID: 26462029 Free PMC article.
-
Complement and macrophage crosstalk during process of angiogenesis in tumor progression.J Biomed Sci. 2015 Jul 22;22(1):58. doi: 10.1186/s12929-015-0151-1. J Biomed Sci. 2015. PMID: 26198107 Free PMC article. Review.
-
Following Chemotherapy: Serum Cytokine (Tumor Necrosis Factor, Interleukin-2, Interleukin-11), Immunoglobulin, Complement, Vascular Endothelial Growth Factor Levels, and the Systemic Symptoms like Capillary Leak Syndrome.Biomark Cancer. 2019 Jun 10;11:1179299X19854447. doi: 10.1177/1179299X19854447. eCollection 2019. Biomark Cancer. 2019. PMID: 31217693 Free PMC article.
-
Complement in Metastasis: A Comp in the Camp.Front Immunol. 2019 Apr 3;10:669. doi: 10.3389/fimmu.2019.00669. eCollection 2019. Front Immunol. 2019. PMID: 31001273 Free PMC article. Review.
-
Potential biomarkers for lung cancer screening.Transl Lung Cancer Res. 2014 Jun;3(3):139-48. doi: 10.3978/j.issn.2218-6751.2014.06.04. Transl Lung Cancer Res. 2014. PMID: 25806293 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous